These results suggest that EPHA3, EPHA7 and EFNA4 are involved in BrCa development and could predict the prognosis of patients with BrCa in various subtypes and in those receiving different chemotherapy regimens. This evidence concerns the gene EPHA3 and invasive breast carcinoma.